Threat to three DMTs removed after manufacturers cut prices

Manufacturers of three relapsing multiple sclerosis drugs have cut prices to remain available to Britain's National Health Service (NHS). They are all diseases modifying therapies (DMTs). In January, I brought you news that five such drugs were under threat, having been found to be not cost-effective as long-term therapy options. In a draft recommendation from …

Advertisement

New trial to see if older people with MS could stop use of DMTs

A clinical study is to look at whether older people with MS can stop using disease modifying therapies (DMTs). The proposal has left me in two minds. The idea seems to be that those who have not any relapses for a few years could quit the treatment. I will be 65 this week and so …

HSCT is superior to DMTs say Swedish researchers

At last, independent researchers have endorsed autologous hematopoietic stem cell tranplantation (HSCT) as a treatment of choice for multiple sclerosis. Well, treatment for relapsing MS, anyway. The study “Autologous haematopoietic stem cell transplantation for neurological diseases” was published in the Journal of Neurology, Neurosurgery & Psychiatry. In it, Swedish researchers, from Uppsala University, say autologous HSCT …

Cure for multiple sclerosis: Are we close?

I keep reading about potential cures for multiple sclerosis but how lose are we? Let us take a look at the situation. Researchers and the medical profession already know that MS is a complicated disease with numerous symptoms. Also, they know that that it is not completely understood. That being the case, it is difficult …

Why are DMTs – Drugs to treat MS – Resisted by so Many?

Many people with multiple sclerosis await the launch of each new disease modifying therapy (DMT), hoping it will bring some improvement. Meanwhile, a significant number of those in the same situation seem to ignore a new drug and carry on regardless. But why? Well, there are a number of reasons; let’s take a look at a …